LAVA Therapeutics NV
LVTX
查看詳細走勢圖
1.740USD
0.0000.00%
收盤 02/06, 16:00（美東）報價延遲15分鐘
45.77M總市值
虧損本益比TTM
盤中分時
1分
30分
1小時
日k
週k
月k
日k
今天
0.00%
5天
0.00%
1月
0.00%
6月
+13.73%
今年開始到現在
0.00%
1年
+82.10%
查看詳細走勢圖
TradingKey 股票評分
由於缺少必要的數據，暫時無法對該公司進行評分
LAVA Therapeutics NV新聞
即將為您帶來更多新聞，敬請期待。 。 。
財務指標
每股收益
由於公司未披露，未能獲取相關數據
營業總收入
由於公司未披露，未能獲取相關數據
LAVA Therapeutics NV簡介
LAVA Therapeutics NV, formerly known as Lava Therapeutics BV, is a provider of biotechnology research and development services based in the Netherlands. The Company focuses of developing next generation Vdelta T cell engaging bispecific antibodies to fight cancer.
公司代碼LVTX
公司LAVA Therapeutics NV
CEOMr. Stephen A. Hurly
網址https://www.lavatherapeutics.com/
相關品種
+3.63%
+3.17%
+0.93%
+1.99%
+1.78%
+1.53%
-0.96%
+4.49%
+2.10%
+10.00%
+2.72%
+4.07%
+1.81%
+4.17%
+0.72%
+1.06%
+2.46%
0.00%
+0.53%
+0.56%熱門品種
278.120
+2.210 (+0.80%)
185.410
+13.530 (+7.87%)
71232.910
+1631.730 (+2.34%)
282.580
+22.390 (+8.61%)
2111.590
+8.770 (+0.42%)
411.110
+13.900 (+3.50%)
4952.980
+142.360 (+2.96%)
63.303
+0.206 (+0.33%)
1.182
+0.004 (+0.35%)
157.098
+0.057 (+0.04%)
